Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 9,260.00
-20.00 (-0.22%)
Apr 30, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 51.21 billion as of April 30, 2026. Its market cap has decreased by -22.45% in one year.
Market Cap
51.21B
Enterprise Value
38.71B
Revenue
27.62B
Ranking
n/a
PE Ratio
11.46
Stock Price
9,260.00
Market Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 51.21B, a decrease of -82.19%. That is a compound annual growth rate of -63.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 51.21B | -5.99% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 68.19T |
| Celltrion | 42.76T |
| ALTEOGEN | 20.15T |
| Samsung Epis Holdings | 13.91T |
| MYUNGMOON Pharm co.,Ltd | 59.77B |
| HASS Corp. | 59.44B |
| Gencurix | 55.76B |
| EOFLOW | 51.11B |